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Abstract
Objective—Weight gain is an important risk factor for gastroesophageal reflux disease (GERD);
however, whether weight loss can lead to resolution of GERD symptoms is not clear. Our aim was
to measure the impact of weight loss on GERD symptoms.
Design and Methods—In a prospective cohort study at a tertiary referral center, overweight/
obese subjects (BMI 25-39.9 kg/m2) were enrolled in a structured weight loss program. Weight
loss strategies included dietary modifications, increased physical activity and behavioral changes.
At baseline and at 6 months, BMI and waist circumference were measured and all participants
completed a validated reflux disease questionnaire.
Results—A total of 332 adult subjects, mean age 46 years and 66% women were prospectively
enrolled. At baseline, the mean body weight, BMI, and waist circumference were 101 (±18) kg, 35
(±5) kg/m2 and 103 (±13) cm. At 6 months, majority of the subjects (97%) lost weight (average
weight loss: 13 ± 7.7 kg) and as compared with baseline, there was a significant decrease in the
overall prevalence of GERD (15 vs. 37%; P < 0.01) and the mean GERD symptom score (1.8 vs.
5.5; P < 0.01). Overall, 81% of the subjects had reduction in GERD symptom scores; 65% had
complete resolution and 15% had partial resolution of reflux symptoms. There was a significant
correlation between % body weight loss and reduction in GERD symptom scores (r = 0.17, P <
0.05).
Conclusions—In conclusion, the overall prevalence of GERD symptoms is high (37%) in
overweight and obese subjects. A structured weight loss program can lead to complete resolution
of GERD symptoms in the majority of these subjects.
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Over the past two decades, the prevalence of gastroesophageal reflux disease (GERD) has
increased in the western population with the overall prevalence in the general population
ranging from 10 to 20% (1-3). The exact etiology for the rising prevalence of GERD is not
clear. Although there are no gender or racial predispositions for GERD development (4,5),
various lifestyle factors including increased consumption of dietary fats, smoking, and
alcohol and change in BMI are potential risk factors that can lead to GERD (6-10). Several
studies have suggested that weight gain and/or obesity can play a major role in the
development of GERD (9-17) through mechanical changes in the gastroesophageal junction
and/or altered metabolic milieu from visceral fat (lower adiponectin and increase in
interleukin-1β, tumor necrosis factor-α) (18).
Over the past few decades, the prevalence of obesity in the United States has more than
doubled. Recent results from the 2007-2008 National Health and Nutrition Examination
Survey (NHANES), using measured height and body weight, indicated that an estimated
68% of US adults were overweight (BMI > 25 kg/m2) and of those, 34% were obese (19). It
seems intuitive that the worsening obesity epidemic and the rising prevalence of GERD
symptoms may point to a cause and effect relationship. In addition, there also appears to be
a dose–response relationship between increasing BMI and occurrence of GERD and related
complications like erosive esophagitis (9,16), Barrett's esophagus (fourfold) (20) and
esophageal adenocarcinoma (16) as compared with normal weight individuals (BMI < 25
kg/m2).
Considering the dose–response relationship between obesity and occurrence of GERD and/
or its complications, an inverse relationship between weight loss and GERD symptoms
would be expected. Previous data on the impact of weight loss achieved through various
lifestyle (dietary changes and physical activity) (21-25) or surgical methods (Roux-en-Y
gastric bypass or vertical band gastroplasty) (26-30) on GERD symptoms are scarce and
with conflicting results (31). A systematic review evaluating the effects of various life style
changes on GERD symptoms suggested that weight loss and head of bed elevation could
improve symptoms of GERD (32). However, the impact of a structured weight loss program
on GERD symptoms in overweight and obese subjects has not been prospectively evaluated.
The aims of the current study were to assess (i) the prevalence of GERD symptoms in
overweight and obese subjects and (ii) impact of weight loss on GERD symptoms.
Methods
Study details
Obese and overweight subjects were prospectively enrolled at the University of Kansas
Medical Center to test the effectiveness of phone based vs. traditional face-to-face clinic
program for weight loss and weight maintenance. After enrollment, participants were
randomized to a weight management program, delivered either by a group conference phone
call or by a traditional face-to-face clinic group. The initial 6 months of the program were
aimed at ≥10% body weight loss from baseline and the subsequent 12 months were targeted
at body weight maintenance. The study was approved by the local institutional review board.
The inclusion and exclusion criteria for participating in this structured weight loss program
were:
Inclusion criteria—(i) Age 18-65 years, (ii) BMI of 25-39.9 kg/m2, and (iii) subjects who
were cleared for participation by their primary care physicians.
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Exclusion criteria—(i) subjects who had participated in another weight loss research
project during the previous 6 months, (ii) weight loss of >5% of body weight within
previous 12 months, (iii) women pregnant during the previous 6 months, lactating, or
planning pregnancy within 18 months, (iv) serious medical risks such as uncontrolled
diabetes or hypertension, recent cardiac event (i.e., heart attack, angioplasty, and
arrhythmia) or cancer, (vi) eating disorders such as anorexia nervosa or bulimia, (vii) serious
psychiatric disorder, (viii) adherence to specialized diet regimes, e.g., multiple food
allergies, vegetarian, macrobiotic, etc., (ix) lack of access to grocery store or inability to
prepare a meal (i.e., military and college student), (x) severe arthritis or other reasons for
restricted mobility, and (xi) BMI >39.9.
Participant enrollment
Subjects from the general population were recruited through newspaper advertising, email
messages, public service messages, media contacts, and word of mouth. Interested
individuals had a brief phone screen to determine their eligibility for participation in the
study. All subjects enrolled in the study were required to submit a medical clearance
certificate from their primary care physicians.
All participants had their demographic information, presence of comorbidities, smoking and
alcohol history, use of acid suppressive medications including proton pump inhibitor (PPIs)
and histamine receptor 2 antagonist, BMI (kg/m2), and waist circumference recorded at
baseline and during follow-up visits. The following definitions for BMI were used; BMI <25
normal weight, BMI 25-29.9 as overweight, BMI ≥30-34.9 as obese and BMI ≥35 as
severely obese. For men, a waist circumference of ≥102 cm and for women waist
circumference ≥88 cm was considered abnormal.
Weight loss program
The participants were stratified by gender to the weight management program delivered by a
group conference phone call or by a traditional face-to-face clinic group with an overall
enrollment of ~50% male and 50% female in each group.
Strategies for losing weight
At the beginning of the weight management program, all participants received a
comprehensive notebook that included instructions on weight loss and maintenance, various
diets, exercise protocol, calendars, and instruction on timelines for class meetings. The
target body weight reduction was 10% of baseline weight at 6 months.
Dietary modifications—To achieve target weight loss, participants were instructed to
reduce their total calorie intake to 1,200-1,500 cal/day using commercially available
prepackaged meals, combined with fruits, vegetables, and beverages. Participants were
asked to consume a minimum of three shakes at ~100 kcal each, two entrees between 200
and 270 kcal each, and five fruits or vegetables per day.
Physical activity—Self-directed instructions were provided to all participants to undergo
moderately vigorous home-based physical activity of walking/other exercise of 15-60 min/
day up to 5 days per week. The exercise progression started at 45 min/week (3 days/week,
15 min/day) and progressed to 300 min/week (5 days/week, 60 min/day) by week 12.
Behavioral strategies—Several behavioral strategies including behavior shaping, goal
setting, self-monitoring, feedback and reinforcement, social support, problem solving, and
relapse prevention were conducted by in-class discussions and activities and regular out-of-
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class assignments to help participants modify their lifestyles for achieving targeted weight
loss.
Follow-up meetings
Group meetings of 60 min duration were held weekly during the initial 6 months. During
these group meetings, the initial 10 min were devoted to weight measurements, calculations
on physical activity, and assessment of compliance to dietary protocol including number of
fruits and vegetables and prepackaged meals consumed per week. Following this, a 30-min
lesson on behavioral modifications including nutrition, physical activity, and lifestyle
modifications was presented by a health educator. The remaining 20 min consisted of group
discussion, problem solving and/or assignments designed to help the participants practice
and develop the behavioral strategies for successful weight loss. Similar instructions for
losing weight were delivered as group conference phone calls that were identical to the
traditional face-to-face group clinics and were conducted by a health educator. Participants
were required to email, fax, or call in their weekly data and self-reported weights the
evening before the day of class. The class schedule included check-in questions, data review
(use of prepackaged meals, fruits and vegetables, physical activity etc.), lessons and problem
solving, and also the assignments for the upcoming week.
Diagnosis of GERD and recording of symptoms at baseline and follow-up
All participants enrolled in this weight loss program completed a validated GERD
questionnaire (reflux disease questionnaire (RDQ)) at baseline and follow-up visits. The
RDQ comprises of 12 questions; six each related to reflux symptom frequency and severity
and each question was assigned a score of 0-3. This questionnaire pertains to three major
components—heartburn, regurgitation, and dyspepsia. Based on the response a cumulative
additive score on response to all the 12 questions could range from 0 to 36. For the current
study, the score was calculated based on the responses only to heartburn and regurgitation
with a score ranging from 0 to 24. Based on previous studies using the RDQ, the presence of
GERD was defined as RDQ score of ≥2 with at least weekly heartburn and/or regurgitation
symptoms (2). Severity rating of GERD symptoms was also based on the responses in the
questionnaire: severity score of 1 was rated as mild, 2 as moderate, and 3 as severe GERD
symptoms. The RDQ questionnaire has been previously validated and has scored highly on
multiple criteria including internal consistency, item discrimination, test–retest reliability,
and regression with specialty physician diagnosis (33). Data suggests that RDQ performs
well across different populations and correlates well with treatment responses (33,34).
All participants completed the RDQ at 6-month follow-up regardless of changes in body
weight and waist circumference. Changes in RDQ questionnaire score were used to define
changes in GERD symptoms. At 6-month follow-up, complete resolution of GERD was
defined as a RDQ score of 1 or less, partial improvement in GERD as any decrease in RDQ
and worsening GERD if there was any increase in the baseline RDQ score.
Data collection, assessment of outcomes, and statistical analysis
Outcome data, body weight and other physical findings were recorded in the clinic (for both
phone and clinic groups) at regular intervals. Participants of both groups also reported by
phone or during clinic visit the number of prepackaged meals consumed and estimated
physical activity.
Descriptive statistics were calculated at baseline and follow-up. Paired t-test was used to
compare changes in GERD symptoms scores, body weight, and waist circumference
between baseline and 6-month follow-up. Presence of GERD, heartburn, and regurgitation
symptoms with varying degrees of weight loss (<5, 5-10, and >10%), and decrease in waist
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circumference (≤5, 5-10, and >10 cm) were also compared using χ2 test. Pearson's
correlation coefficients (r) were calculated to evaluate the association between changes in
overall GERD, heartburn, and regurgitation symptom scores with mean and percent body
weight and waist circumference changes. A P value <0.05 was considered significant.
Post hoc power estimates suggested that the proposed analyses were adequately powered in
this study. Achieved power was 0.99-1 and 1 for paired t-test and χ2 test, respectively.
Power of 0.88 was achieved for testing the association between change in GERD symptoms
score and percent body weight change. For the other associations, however, power was not




A total of 332 subjects were enrolled in the weight loss program and completed the RDQ at
baseline and at 6-month follow-up. The mean age was 46 (range 19-66) years, 80% were
Caucasians, 15% African-Americans and included 66% women. The mean weight, BMI,
and waist circumference were 101 (±18) kg, 35 (±5) kg/m2, and 103 (± 13) cm, respectively
and the vast majority had a BMI >35 (83%) and a waist circumference >100 cm (58%)
(Table 1). Eighty nine subjects (27%) had a history of hypertension, 26 (8%) had diabetes
mellitus and one with heart disease.
Consecutive subjects were randomized to either the clinic based (167 subjects) or phone
based (165 subjects) weight loss program and each group comprised of 41 and 33% subjects
with GERD, respectively (P = not significant).
Overall prevalence of GERD in the study population
The baseline prevalence of GERD in this cohort was 37% (124/332). Regurgitation (n = 86;
26%) was reported more frequently than heartburn (n = 61; 18%) with approximately a third
of the symptomatic subjects (n = 36; 29%) experiencing moderate to severe GERD
symptoms.
GERD symptoms scores during follow-up
The majority of the subjects (97%) lost weight at the 6-month follow-up period with a mean
weight loss of 13.1 (±7.7) kg and a mean decrease in waist circumference by 10.6 (±9.1) cm.
Compared with baseline, there was a significant decrease in the overall prevalence of GERD
symptoms (15 vs. 37%; P < 0.01) with significant improvements in overall symptom,
heartburn and regurgitation scores (all P < 0.01). The mean reduction in GERD symptom
score was 1.3 (±3.5) (Tables 1 and 2). There was no significant difference in the degree of
weight loss and/or GERD symptom scores between the two groups i.e., those enrolled in
phone vs. clinic based weight loss programs. Among subjects who had GERD at baseline,
81% had a reduction in GERD scores (65% with complete resolution and 15% with partial
resolution), 13% had no change whereas 7% subjects had worsening of their GERD
symptoms. There was no significant difference in the use of acid suppressive medications
(including PPIs and histamine receptor 2 antagonists) at baseline (11%) and during follow-
up (8%), (P = not significant) (Table 1).
Correlation between degree of weight loss and GERD scores
A positive correlation was observed between the degree of body weight loss (percent
change) and change in GERD symptom scores over the 6-month follow-up period. There
was a significant improvement in overall GERD symptoms with percent body weight loss
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(Pearson's correlation coefficient, r = 0.17, P < 0.05) (Figure 1). Similarly, a significant
association between percent body weight loss and decrease in heartburn scores was noted (r
= 0.12, P < 0.05) however, the correlation between degree of body weight loss and
regurgitation scores was not significant (r = 0.12, P = not significant). There was no
significant correlation between decrease in waist circumference (mean or percent) and
overall GERD, heartburn or regurgitation symptom scores; r = 0.05, 0.08, and 0.06,
respectively (all P = not significant) (Figure 1).
GERD symptoms and gender differences
Subjects were then sub-grouped into different body weight reduction categories of <5, 5-10,
and ≥10% and decrease in waist circumference to <5, 5-10, and ≥10 cm. There was no
significant change in overall GERD symptom scores with <5% weight loss of baseline body
weight for all subjects. However, a weight loss of 5-10% lead to a significant reduction in
overall GERD scores (P < 0.05) in women. Whereas among men, a significant improvement
in GERD symptom scores (P < 0.01) was observed after a weight loss of ≥10% of baseline
body weight. Similarly, there was no significant change in overall GERD symptom scores
with a <5 cm waist circumference reduction (from baseline waist circumference). However,
losing 5-10 cm waist circumference led to a significant reduction in GERD symptoms (P <
0.01), among women. In men, there was a significant reduction in GERD symptoms (P <
0.01) with a waist circumference decrease of ≥10cm (Table 3).
Discussion
Over the last few decades there has been steady increase in the prevalence of GERD
(1,2,3,9,35) and several recent studies have suggested a significant association between
obesity and GERD (9-17). The prevalence of GERD has been shown to increase with
increasing BMI (9,16,20) and ranges from 59 to 79% among extremely obese subjects
(35-37). As conservative measures for the management of GERD symptoms, although
various lifestyle (including weight loss) and dietary modifications have been suggested by a
variety of guidelines and consensus conferences, there is no evidence-based prospective data
to support the efficacy of these measures (38). The results of our study showed that GERD
symptoms were prevalent in 37% of overweight and/or obese individuals enrolled in a
weight loss program. Furthermore, results of our prospective study showed that weight loss
led to a significant improvement in GERD symptoms, thus establishing weight loss as an
important life style modification for the treatment of GERD. In this study cohort, weight
loss over a 6-month period, the majority of subjects (81%) experienced a reduction in GERD
symptoms and 65% of the study subjects with complete resolution of reflux symptoms.
Contemporary studies evaluating the effect of weight loss in GERD subjects are lacking and
ours is the largest prospective trial conducted on this topic. One Swedish study from 1999
evaluated only 34 overweight patients (BMI >23, excluding severely obese) and did show a
positive correlation between weight loss and improvement of GERD symptom (21). Another
study, as yet in abstract form, was exclusively conducted in obese (BMI 30-39) subjects and
also showed a positive correlation between improvement in GERD symptoms with decrease
in BMI as well as reductions in waist-hip ratio; odds ratios of 1.10 (95% confidence
intervals: 1-1.2) and 1.08 (95% confidence intervals:1-1.1), respectively (35).
However, a few previous studies including severely obese subjects enrolled in a low calorie
diet based weight loss protocol failed to show any significant change in GERD symptoms
despite a weight loss of up to 10 kg (23,25) or more (24). These varied results of weight loss
on GERD symptoms could be because of small sample size, gender differences, wide
variation in BMI of subjects (23 vs. 43), and use of different weight loss methods (various
lifestyle changes vs. surgical approaches) (21-35). Furthermore, a number of lifestyle
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intervention treatments have been attempted for GERD—low calorie diet, use of fruits/
vegetables, and physical activity; individually each intervention has no direct correlation
with GERD improvement as shown in previous population-based studies (13,22,23) and a
recent meta-analysis (32). Previous studies have reported no change in GERD with weight
loss achieved by low calorie diet alone (25) or in combination with gastric surgery (vertical
band gastroplasty) (23) without increase in physical activity. These results suggest that a
structured weight loss program (combination of diet, physical activity, and behavioral
changes) may be necessary for impact on GERD symptoms.
Studies have shown a dose–response relationship between weight gain (BMI) and
occurrence of GERD and complications of erosive esophagitis, Barrett's esophagus and
esophageal adenocarcinoma (9,13,16,20). A questionnaire based large cohort study of
middle-aged women nurses, over a period of 25 years, demonstrated a clear dose–dependent
increase in the frequency of GERD symptoms with increase in BMI. Overweight and obese
women had two to three times higher chance of having GERD symptoms as compared with
those with normal weight (13) suggesting a temporal association between weight change and
GERD symptoms. We observed a similar association between the degree of weight loss and
improvement in GERD symptoms further strengthening the concept of a direct relationship
between these two variables. However, some gender differences were noted—a weight loss
of 5-10% led to a significant reduction in overall GERD scores (P < 0.05) in women;
whereas among men, a significant improvement in GERD symptom scores (P < 0.01) was
observed after a weight loss of ≥10% of baseline body weight. Similar to this concept, new
onset or worsening of pre-existing GERD may occur only after certain threshold weight
change as was reported in previous study by Rey et al. (39) In that study subjects who
gained >5 kg showed three times significantly higher frequency of new onset GERD (39).
Although a positive and significant correlation between weight loss and GERD scores was
noted, it appears that the correlation is not linear and more complex. The change in GERD
scores among obese subjects probably occurs secondary to multiple factors such as gender,
proportional changes in abdominal vs. peripheral fat weight, hormonal (adiponectin), and
genetic factors besides weight loss. In the current study, not all obese subjects with GERD
who lost weight had reduction in GERD scores, 13% had no change whereas 7% subjects
had worsening of their GERD symptoms. Therefore, weight change is probably one of the
factors that affect GERD symptoms.
Therefore, a small percentage of overweight and or obese subjects may not have resolution
of GERD with weight loss; future trials defining predictors of GERD improvement in
overweight/obese subjects are required. At baseline, a small number (11%) of subjects used
PPIs and this decreased to 8% at the 6-month follow-up however, the number of subjects
using PPIs was small and therefore no inference can be made on whether obese subjects
with GERD symptoms would need less or no medications after losing weight.
There were a few limitations to this study. The impact of weight gain on GERD occurrence
could not be evaluated as the majority (97%) of subjects lost weight at 6 months and had
improvement in their reflux symptoms. Although this is a prospective longitudinal study, the
treatment was not randomized and lacks a control group. Unlike most previous studies that
specifically included either over-weight or severely obese populations only, we included
both over-weight and obese subjects (BMI 25-39.9) but the majority were healthy and
required a clearance letter from their primary care physicians for participating in the study;
hence study results may not be generalized to all overweight, obese individuals. In the
current study, subjects lost weight by combination of dietary, behavioral, and physical
activity changes; therefore the contribution of each modality separately on GERD symptoms
could not be evaluated. Finally, although, we used a validated questionnaire (RDQ) for
diagnosing and monitoring GERD symptoms, endoscopy and/or pH monitoring was not
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performed. Despite these limitations, the results of this prospective study are highly
suggestive of obesity as a major contributor to GERD and that weight loss can lead to
resolution of GERD symptoms in the majority of overweight and/or obese subjects. The
large patient population, evaluation of both men and women, use of a structured weight loss
program and an objective, validated symptom questionnaire are strengths of our study.
These results have significant clinical implications. Using weight loss as an important first
line treatment for GERD in overweight, obese individuals could potentially result in
significant cost savings on medical treatment, prevent complications of GERD, as well as
improve quality of life and overall health status. These categories of over-weight and obese
subjects constitutes a major part (68%) of the US population (2008 NHANES consensus)
(19) and hence these results could have wide-spread clinical implications for management of
GERD. The estimates show that in excess of 10 billion US dollars a year are spent on
medical therapy (PPIs) (40) thus presenting a significant economic burden on the health-care
system.
In summary, ~40% of adult subjects enrolled in weight loss programs that were overweight
and/or obese experienced GERD symptoms. Through a structured weight loss program
including dietary, physical activity and behavioral changes, the majority of these subjects
achieved complete resolution of their GERD symptoms. There appeared to be a dose–
response relationship between the degree of body weight loss and resolution of GERD
symptoms and the threshold weight loss for such an improvement was lower in women
compared to men (5-10 vs. >10% body weight reduction).
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Scatter plot diagram showing dose-response relationship between gastroesophageal reflux
disease symptom scores and (a) degree of weight loss, r = 0.17, P < 0.05, and (b) reduction
in waist circumference, r = 0.05, P = not significant.
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TABLE 1
Clinical characteristics of all subjects enrolled in a weight loss program (baseline and 6 months)
Variable Baseline (N = 332) 6-month follow-up (N = 332) P
Weight (kg) 100.7 ±18.1 87.6 ±16.7 <0.01
BMI (kg/m2) 34.7 ±4.6 30.2 ±5.0 <0.01
Waist circumference (cm) 102.7 ±12.9 92.1 ±13.0 <0.01
Subjects with GERD symptoms 124 (37%) 51 (15%) <0.01
GERD symptom score 2.1 ±3.7 0.8 ±2.6 <0.01
Heartburn score 0.6 ±1.4 0.3 ±1.1 <0.01
Regurgitation score 0.9 ±1.6 0.3 ±0.9 <0.01
PPIs/H2RAs use 35 (11 %) 26 (8%) ns
GERD, gastroesophageal reflux disease; H2RA; histamine 2 receptor antagonist; ns, not significant; PPI, proton pump inhibitor.
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TABLE 2
Change in overall GERD symptom scores (measured by RDQ) with weight loss
Variable Baseline (N =124) 6-month follow-up (N = 124) P
Weight (kg) 100.5 ±18.6 87.7 ±17.3 <0.01
BMI 34.7 ±4.4 30.4 ±4.5 <0.01
Waist circumference (cm) 103.4 + 13.3 93.7 ±11.4 <0.01
Overall GERD score 5.5 ±4.3 1.8 ±3.6 <0.01
Heart burn score 1.6 ±2.0 0.5 ±1.5 <0.01
Regurgitation score 2.3 ±2.0 0.6 ±1.4 <0.01
GERD, gastroesophageal reflux disease; RDQ, reflux disease questionnaire.
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TABLE 3
Threshold body weight loss or waist circumference decrease for improvement in overall GERD symptom









P Heartburn score change P Regurgitation score change P
Men
Percent body weight
loss (%) (N = 105)
5–10 21 ±0.2 ± 2.3 0.71 −0.1 ±0.4 0.33 ±0.2 ± 1.1 0.43
≥10 84 −1.7 ± 3.7 <0.01 −0.5 ± 1.4 <0.01 −0.7 ± 1.6 <0.01
Waist circumference
decrease (cm) (N =
104)
5–10 25 −1.3 ± 4.5 0.17 −0.6 ± 1.4 0.06 −0.2 ± 1.8 0.50




5–10 51 −1.2 ± 3.5 <0.05 −0.3 ± 1.3 0.11 −0.7 ± 1.6 <0.01
≥10 138 −1.5 ±3.3 <0.01 −0.4 ± 1.6 <0.01 −0.7 ± 1.6 <0.01
Waist circumference
decrease (cm) (N =
157)
5–10 79 −1.6 ± 4.1 <0.01 −0.3 ± 1.9 0.12 −0.8 ± 1.5 <0.01
≥10 78 −1.1 ±2.6 <0.01 −0.4 ± 1.2 <0.05 −0.5 ± 1.6 <0.01
All values represent mean ± s.d.
GERD, gastroesophageal reflux disease.
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